MAPT and Alzheimer disease: It is very likely, that yeast models for AD (β-Amyloid, tau, UBB+1), and ALS (e.g., TDP-43, FUS/TLS), will lead to the identification of further ubiquitin-regulated protein degradation pathways that potentially underlie neuronal dysfunction and cell loss.